|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.01 USD | +0.39% |
|
-0.03% | +16.96% |
| Capitalization | 10.83B 9.19B 8.6B 8.06B 14.88B 984B 16.31B 100B 38.76B 462B 40.6B 39.76B 1,676B | P/E ratio 2025 * |
20.1x | P/E ratio 2026 * | 18.7x |
|---|---|---|---|---|---|
| Enterprise value | 13.22B 11.23B 10.5B 9.84B 18.17B 1,202B 19.91B 123B 47.33B 565B 49.58B 48.55B 2,046B | EV / Sales 2025 * |
2.23x | EV / Sales 2026 * | 2.06x |
| Free-Float |
85.73% | Yield 2025 * |
0.67% | Yield 2026 * | 0.71% |
Last Transcript: Encompass Health Corporation
| 1 day | +0.39% | ||
| 1 week | -0.03% | ||
| Current month | -7.06% | ||
| 1 month | -4.80% | ||
| 3 months | -12.76% | ||
| 6 months | -10.37% | ||
| Current year | +16.96% |
| 1 week | 105.76 |  | 108.49 |
| 1 month | 105.71 | | 117.5 |
| Current year | 87.85 | | 127.99 |
| 1 year | 87.85 | | 127.99 |
| 3 years | 51.15 | | 127.99 |
| 5 years | 44.33 | | 127.99 |
| 10 years | 30.26 | | 127.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Tarr
CEO | Chief Executive Officer | 63 | 2016-12-28 |
Douglas Coltharp
DFI | Director of Finance/CFO | 64 | 2010-05-05 |
Patrick Tuer
COO | Chief Operating Officer | 41 | 2025-04-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Tarr
BRD | Director/Board Member | 63 | 2016-12-28 |
Joan Herman
BRD | Director/Board Member | 71 | 2013-01-24 |
Leslye Katz
BRD | Director/Board Member | 70 | 2013-01-24 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.44% | 5 M€ | 0.00% | - |
| 1.39% | 2 M€ | +9.31% | - |
| 1.09% | 1 M€ | -.--% | - |
| 1.09% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.39% | -0.03% | +10.53% | +87.35% | 10.83B | |
| -0.57% | +3.21% | +22.11% | +46.95% | 18.78B | |
| -0.63% | -3.77% | -23.82% | -52.14% | 14.56B | |
| -0.49% | -0.63% | -2.86% | +51.88% | 11.23B | |
| -1.99% | +2.60% | -18.26% | -29.64% | 10.15B | |
| -0.98% | +0.70% | +23.18% | +83.30% | 10.19B | |
| -0.37% | -0.37% | -22.16% | - | 8.11B | |
| +0.60% | +1.65% | +22.90% | +207.67% | 7.24B | |
| -0.92% | -2.62% | -5.07% | -47.19% | 5.4B | |
| -0.38% | -1.65% | +47.01% | +151.58% | 4.25B | |
| Average | -0.52% | -0.17% | +5.36% | +55.53% | 10.07B | |
| Weighted average by Cap. | -0.56% | -0.02% | +3.57% | +44.17% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.93B 5.04B 4.71B 4.42B 8.15B 539B 8.94B 55.05B 21.24B 253B 22.25B 21.78B 918B | 6.44B 5.47B 5.12B 4.8B 8.86B 586B 9.71B 59.8B 23.07B 275B 24.17B 23.66B 997B |
| Net income | 550M 468M 437M 410M 757M 50.04B 829M 5.11B 1.97B 23.51B 2.06B 2.02B 85.22B | 595M 506M 473M 443M 818M 54.13B 897M 5.53B 2.13B 25.43B 2.23B 2.19B 92.19B |
| Net Debt | 2.39B 2.03B 1.9B 1.78B 3.29B 218B 3.61B 22.21B 8.57B 102B 8.98B 8.79B 371B | 2.45B 2.08B 1.94B 1.82B 3.36B 223B 3.69B 22.72B 8.77B 105B 9.18B 8.99B 379B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-16 | 108.01 $ | +0.39% | 1,324,315 |
| 25-12-15 | 107.59 $ | +0.55% | 1,267,917 |
| 25-12-12 | 107.00 $ | +0.14% | 1,262,557 |
| 25-12-11 | 106.85 $ | +0.42% | 1,281,391 |
| 25-12-10 | 106.40 $ | -1.52% | 1,796,918 |
Delayed Quote Nyse, December 16, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EHC Stock
Select your edition
All financial news and data tailored to specific country editions
